Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
0.2
-
Debt to Equity
0.6
-
Book Value
$--
-
EPS
$-16.2
-
Face value
--
-
Shares outstanding
2,877,926
5 Years Aggregate
CFO
$-29.74 Mln
EBITDA
$-30.24 Mln
Net Profit
$-35.06 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tivic Health Systems Inc (TIVC)
| -62.1 | -35.4 | -40.9 | -85.5 | -85.8 | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Tivic Health Systems Inc (TIVC)
| -75.4 | -80.5 | -97.2 | -83.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Tivic Health Systems Inc (TIVC)
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat... Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas. Read more
-
Co-Founder, CEO & Director
Ms. Jennifer Ernst
-
Co-Founder, CEO & Director
Ms. Jennifer Ernst
-
Headquarters
Fremont, CA
-
Website
FAQs for Tivic Health Systems Inc (TIVC)
What is the current share price of Tivic Health Systems Inc (TIVC) Today?
The share price of Tivic Health Systems Inc (TIVC) is $0.55 (NASDAQ) as of 29-Jun-2026 09:30 EDT. Tivic Health Systems Inc (TIVC) has given a return of -85.84% in the last 3 years.
What is the current PB & PE ratio of Tivic Health Systems Inc (TIVC)?
Since, TTM earnings of Tivic Health Systems Inc (TIVC) is negative, P/E ratio is not available.
The P/B ratio of Tivic Health Systems Inc (TIVC) is 0.15 times as on 29-Jun-2026, a 96 discount to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.05 |
0.02 |
2024 |
-0.01 |
0.01 |
2023 |
-0.02 |
0.04 |
2022 |
-0.01 |
0.02 |
2021 |
-0.03 |
0.02 |
What is the 52 Week High and Low of Tivic Health Systems Inc (TIVC)?
The 52-week high and low of Tivic Health Systems Inc (TIVC) are Rs 5.60 and Rs 0.49 as of 08-Sep-2026.
What is the market cap of Tivic Health Systems Inc (TIVC)?
Tivic Health Systems Inc (TIVC) has a market capitalisation of $ 4 Mln as on 29-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tivic Health Systems Inc (TIVC)?
Before investing in Tivic Health Systems Inc (TIVC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.